Stock listing

Fusion Antibodies Plc

Selected listing: FAB · LSE · GBX · GB

Fusion Antibodies Plc (LSE:FAB), Health Services. Latest release Oct 5, 2026: Launch of new customer-focused website.

FAB:LSEGBXGBUpdated October 2, 2026
Fusion Antibodies Plc logo
Ticker
LSE:FAB
Asset type
Stock
Sector
Health Services
Industry
Medical/Nursing Services
Exchange
LSE
Currency
GBX

About Fusion Antibodies Plc

The company specializes in providing antibody engineering services and solutions to the biopharmaceutical industry. Fusion Antibodies focuses on advancing therapeutic antibody development to support its clients in creating innovative treatments.

Latest news from Fusion Antibodies Plc

Launch of new customer-focused website

October 5, 2026

REPLACEMENT: Final Results

September 15, 2026

Grant of Canadian Patent for OptiMAL

September 9, 2026

Notice of acceptance of patent in Australia

August 6, 2026

Notice of allowance of patent in Canada

June 22, 2026

All Fusion Antibodies Plc news →

Events

Replays

  • FUSION ANTIBODIES PLC (FAB) — Full year results briefing

    Tue, Sep 15, 2026 · 06:30 AM ET

    Watch

  • FUSION ANTIBODIES PLC (FAB) — Interim Results

    Tue, Nov 25, 2025 · 06:00 AM ET

    Watch

  • FUSION ANTIBODIES PLC (FAB) — Full year results briefing

    Mon, Sep 15, 2025 · 06:00 AM ET

    Watch

Research Fusion Antibodies Plc

Fusion Antibodies Plc company profile

View the public company page for Fusion Antibodies Plc on 6ix.

Fusion Antibodies Plc news

Read company news and market updates connected to Fusion Antibodies Plc.

Fusion Antibodies Plc investor events

Find investor webinars, events, and replay context for Fusion Antibodies Plc.